A Multicenter, Open-Label Study to Investigate the Safety and Tolerability of Intravenous Lacosamide as Replacement for Oral Lacosamide in Children (≥ 4 to < 17 Years of Age) With Epilepsy

Trial Profile

A Multicenter, Open-Label Study to Investigate the Safety and Tolerability of Intravenous Lacosamide as Replacement for Oral Lacosamide in Children (≥ 4 to < 17 Years of Age) With Epilepsy

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 23 Jul 2018

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Epilepsy
  • Focus Adverse reactions
  • Sponsors UCB
  • Most Recent Events

    • 16 Jul 2018 Planned End Date changed from 1 Aug 2020 to 1 Jun 2020.
    • 16 Jul 2018 Planned primary completion date changed from 1 Aug 2020 to 1 Jun 2020.
    • 24 Jun 2018 This trial has been completed in Germany
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top